Radiation-Induced Cancer Mortality Risk Climbs With Full-Body CT Exposure
This article was originally published in The Gray Sheet
The greatest cancer mortality risk stemming from full-body CT scans is sustained by the lungs, Columbia University researchers David Brenner, PhD, and Carl Elliston write in the September issue of Radiology
You may also be interested in...
Lead immuno-oncology asset NC318 targeting Siglec-15 showed encouraging early activity in patients refractory to PD-1/L1 inhibitors, but now Phase II plans are scuttled in lung and ovarian cancers.
Pataday Once Daily Relief Extra Strength is the same formulation as Novartis' Rx Pazeo. It will be the first OTC eye drop indicated for allergy itch with 24-hour efficacy, available online in September and through retailers in early 2021.
Bristol makes its own deal with Celgene ally Dragonfly, while Gilead ends virology partnerships with Durect and Precision BioSciences.